Satu Kuokkanen: Thyroid Autoimmunity and Elevated TSH Linked to Lower Live Birth Rates in Infertility Trials
Satu Kuokkanen, Assistant Professor at NYU Long Island School of Medicine, shared a post on LinkedIn:
“We recently analyzed data from two major NIH-funded fertility trials (PPCOS II and AMIGOS) to explore how thyroid function markers impact pregnancy outcomes in women with infertility.
Key Finding:
Women with TSH ≥2.0 mU/L combined with TPO antibodies ≥30 U/mL had:
↓ 45% lower live birth rate
↑ Higher risk of pregnancy loss and early preterm birth
These findings may suggest that even mild thyroid dysfunction, when paired with thyroid autoimmunity, may significantly impact reproductive success—and may warrant closer screening thresholds in fertility care.
This data is hypothesis generating and therefore further research is needed, but this adds to the evidence linking thyroid health and pregnancy outcomes.
Read the full paper: Fertility and Sterility, Volume 123, Issue 5, p873-882, May 2025.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Jan 28, 2026, 16:59Unlocking the Potential of Menstrual Blood in Health Testing – Global Women’s Health Innovation Conclave
-
Jan 28, 2026, 16:57New Insights on Oocyte Yield in Endometriosis and PCOM – RBMO
-
Jan 28, 2026, 16:51Transform Your Expertise with ESHRE eCampus Learning – ESHRE
-
Jan 28, 2026, 16:46Accelerate Your Growth at the AP3G National Meeting – ASRM
-
Jan 28, 2026, 16:43Debojit Saha: Unraveling Chromosomal Errors in Aging Human Eggs
-
Jan 28, 2026, 16:38Silvia Vannuccini: RBMO Highlights Key Insights on Adenomyosis Awareness
-
Jan 28, 2026, 16:32Maximilian Attwood: Challenging Medical Misogyny in Endometriosis Research
-
Jan 28, 2026, 16:29Ioakeim Sapantzoglou: New Perspectives on Fetal Growth Restriction and Genetic Testing
-
Jan 28, 2026, 16:26Enhancing Pre-Eclampsia Prediction with Doppler Indices – ISUOG